Mayo Clinic, American Hospital Dubai strengthen collaboration to transform healthcare and medical education in Dubai
American Hospital Dubai, a distinguished member of the Mayo Clinic Care Network and the globally renowned Mayo Clinic, announced an enhanced collaboration marking a milestone in advancing healthcare delivery, medical education, and research in Dubai and the region. The announcement was made at Arab Health 2025, the healthcare industry's premier event being held in Dubai from January 27-30, 2025, at the World Trade Centre.
The strengthened relationship between American Hospital Dubai and Mayo Clinic underscores the shared vision of both institutions to transform patient care, promotes innovation, and further fortifies Dubai's position as a global leader in healthcare excellence.
The enhanced collaboration will focus on optimising clinical practices, improving operational efficiencies at American Hospital Dubai, and integrating cutting-edge technology to elevate the quality of care. A cornerstone of this relationship is establishing Dubai's first Doctor of Medicine (M.D.) medical school, designed with guidance from the Mayo Clinic College of Medicine and Science. This transformative initiative will nurture healthcare leaders and set regional medical education benchmarks.
The establishment of the new medical school is a pivotal achievement, reflecting the shared vision of advancing education and innovation. The medical school's curriculum, aligned with global best practices, will feature state-of-the-art facilities, faculty development programs, and immersive learning experiences.
As a Mayo Clinic Care Network member since 2013, American Hospital Dubai has leveraged its unique access to Mayo Clinic's knowledge and expertise to enhance its clinical capabilities and ensure world-class patient care. This strengthened collaboration builds on that foundation, forging new paths, including developing a healthcare simulation center for advanced medical training, streamlining workflows to boost operational efficiency, and enhancing subspecialty service lines to address complex medical needs, further cementing American Hospital Dubai's position as a leading healthcare provider in the region.
American Hospital Dubai's enhanced relationship with Mayo Clinic extends to research and innovation and Mayo Clinic's expertise will help American Hospital Dubai establish a clinical research infrastructure. Mayo Clinic will also assist American Hospital Dubai with optimising resources, integrating research and clinical operations, and developing new treatment protocols aligning with international standards. Mayo Clinic will also assist American Hospital Dubai to enhance its patient-first approach through clinical and operational advancements, streamlined workflows, and comprehensive care under one roof, which will assist in fostering patient trust and satisfaction, ensuring patients in Dubai and the broader region access advanced care without travelling abroad. It will support the UAE's long-term healthcare sustainability and innovation goals and reinforce Dubai's commitment to becoming a global hub for medical tourism and healthcare excellence.
Sherif Beshara, group CEO of American Hospital Dubai, welcomed the deepening ties between Mayo Clinic and American Hospital Dubai. "We are excited to take our collaboration with Mayo Clinic to new heights. Clinical excellence and education are partners in enabling transformative healthcare. Our expanded scope is committed to setting new benchmarks in patient care by enhancing clinical practices and promoting education and research. American Hospital Dubai will continue its mission to further enhance Dubai's status as a global hub in medical excellence and knowledge building.'
Biju Samkutty, COO of Mayo Clinic International and Enterprise Automation, highlighted the significance of this initiative: "The establishment of this medical school is a testament to our shared commitment to clinical and educational excellence. By integrating high-quality education with exceptional patient care, we are shaping a future where innovation and compassion define healthcare."
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
4 hours ago
- Zawya
New Mayo Venture Partner program announced to accelerate innovation
Dubai, United Arab Emirates — Mayo Clinic's Business Development team, consistently recognized as one of the top commercialization operations among academic medical centers, is expanding its capabilities through a new initiative: the Mayo Venture Partner (MVP) program. In response to the dynamic and evolving healthcare landscape, Mayo Clinic is enlisting industry veterans to create groundbreaking technologies, co-invest in aligned companies and build new ventures from the ground up. The MVP program brings together seasoned entrepreneurs, investors and executives who will leverage their expertise with Mayo Clinic's world-class research and clinical expertise. These leaders will play a pivotal role in identifying high-potential opportunities across Mayo Clinic's research and clinical practices, forming new companies and accelerating innovations that advance patient care. The inaugural MVPs are: Amy DuRoss — Healthcare innovation leader with deep expertise in policy, commercialization and diagnostics. Audrey Greenberg — Company builder, executive leader and expert in launching and scaling ventures across life sciences, healthcare and other industries. Brian Poger — Serial entrepreneur and venture strategist with a track record in digital health and healthcare services. Working in close partnership with the Mayo Clinic Business Development team, the MVPs will help forge strategic collaborations and deliver real-world impact, underscoring Mayo Clinic's enduring commitment to transforming healthcare. To date, the Business Development team has returned more than $1.2B in revenue to Mayo Clinic to support its clinical practice, education and research. Additionally, the team has helped create more than 180 companies, licensed 4,848 Mayo Clinic-created technologies through 2,913 agreements, and issued 4,159 patents. This program and these efforts align with Mayo Clinic's vision to transform healthcare by: Accelerating innovation — Turning cutting-edge research, data and other resources into real-world solutions for patients. Enhancing patient care — Bringing new treatments and technologies to patients that offer cures and the ability to connect with the healthcare system in ways that increase access and decrease costs. Building strategic partnerships — Leveraging external expertise and resources to amplify impact. Mayo Clinic is dedicated to driving progress and expanding its impact through innovation. This initiative is an exciting opportunity for investors, CEOs and innovators to collaborate with Mayo Clinic and be part of a future that prioritizes patient-centric, transformative healthcare solutions. To learn more, visit the Mayo Clinic Business Development website and subscribe to its e-newsletter and follow the Mayo Clinic Ventures LinkedIn page.
Al Etihad
17 hours ago
- Al Etihad
Two Emirati students join advanced research programme at Mayo Clinic
10 June 2025 00:15 HALA AL KHAYAT (ABU DHABI)Reaffirming the UAE's championing of scientific excellence, the Khalifa bin Zayed Al Nahyan Foundation for Humanitarian Work has announced its support for two Emirati female students to join a research training programme at the Mayo Clinic in the move enables Emirati students Moza Al Alili and Hessa Mohammed Saeed Al Mansouri to gain in-depth knowledge and hands-on experience at the Mayo Clinic and enrich the UAE's healthcare system on their programmes are a key pillar of the UAE's strategy to build a new generation of scientists, doctors, and researchers capable of keeping pace with rapid developments in medicine, science, and wise leadership of the UAE has placed educational scholarships at the forefront of its priorities, directing efforts to expand academic partnerships with world-renowned universities and research part of this vision, the Mayo Clinic - ranked among the top research hospitals in the world - has become a favoured destination for Emirati students, offering rare opportunities to engage with advanced applied research and world-class laboratories. Pioneering Research OpportunitiesAs part of the President's Scholarship for Outstanding Physicians, the foundation continues to offer advanced research opportunities for Emirati students at prestigious global institutions such as the Mayo Clinic. The Khalifa bin Zayed Al Nahyan Foundation for Humanitarian Work emphasised that such support lays the foundation for refining national competencies in vital areas like medicine, science, and technology, empowering them to actively contribute to the UAE's research and innovation landscape - aligned with the nation's ambitions for a knowledge-based initiatives, the foundation noted, are not merely investments in individuals, but in the future of the nation. Every scholarship student returns equipped with the power of knowledge, helping to elevate the UAE's standing in the global medical and research arenas. Moza Al Alili: Emirati Researcher Charting Path in GeneticsEmirati student Moza Mohammed Al Alili, a third-year PhD student at the College of Medicine and Health Sciences at UAE University, specialises in Biomedical Sciences. She began her academic journey with a bachelor's degree in Medical Laboratory Science from the Higher Colleges of Technology in Sharjah, graduating with honours. Throughout her studies, she focused closely on genetic disorders related to mitochondrial DNA. After graduation, she worked for three years as a Medical Laboratory Scientist at Khalifa Medical City in Ajman before fully committing to Alili pursued her master's degree in Medical Sciences – Biochemistry and Molecular Biology from the UAE University. Her thesis explored RNA analysis in type 2 diabetes and its relation to bone Al Alili is working on her PhD dissertation, which investigates genetic changes in type 2 diabetes associated with obesity, focusing on how the condition affects bone and the mechanisms of osteocyte (bone cell) communication under disease conditions."My research aims to understand the 'language' of cells through extracellular vesicles - highly specialised communication tools - which could open new doors to more precise and effective treatments," Al Alili Alili is the first PhD student at the UAE University to have her research included in the field of extracellular vesicle extraction, a speciality not yet available at the to a research grant from the Khalifa Bin Zayed Al Nahyan Foundation for Humanitarian Work, under the President's Scholarship for Distinguished Physicians, Al Alili has been given a unique opportunity to train in the Mayo Clinic began her training in early June, in a programme lasting from three months up to a year, under the supervision of Dr. Naureen Javed, an expert in physiology and biomedical Alili said that this technique helps identify the "language" of cells through biological receptors released in vesicles, aiding in the understanding of healing mechanisms and the development of molecular-level Alili emphasised that her achievements would not have been possible without the strong support of the UAE's wise leadership and national institutions - chief among them the Khalifa Bin Zayed Foundation, which opens doors to world-class research and training opportunities."The UAE gives every citizen the chance to grow and supports highly specialised fields that meet the needs of our era," she adds that her goal is to bring this advanced knowledge back home and contribute to developing treatments that reinforce the UAE's leadership in the health and research sectors. Hessa Al Mansouri: Sustainable Health Solutions Come from the LabA graduate student at the College of Medicine and Health Sciences at UAE University, Hessa Mohammed Al Mansouri, believes that scientific research is not just an academic choice but a vital necessity for advancing medicine in the UAE and achieving local scientific self-sufficiency. Al Mansouri is currently pursuing her postgraduate studies at the UAE University's medical college. She was nominated by the university and the Khalifa Bin Zayed Al Nahyan Foundation for Humanitarian Work to apply for the Visiting Research Trainee Programme at the Mayo Clinic lab focuses on extracellular vesicles (EVs) released by beta cells, aiming to understand subtle changes in their content and how these impact cellular communication during the progression of both type 1 and type 2 diabetes."This kind of research directly touches the future of healthcare, as it paves the way for discovering biomarkers that aid in more accurate diabetes diagnosis and in using them as targets for genetic or cellular therapy. The research we conduct today may make a difference in the lives of millions of patients in the future," Al Mansouri passion for scientific research began during her undergraduate years, where she realised the importance of deeply understanding the biological mechanisms of chronic diseases-especially diabetes, which remains one of the region's most significant health challenges."The deeper I dive into understanding the disease from a research perspective, the more I'm convinced that sustainable solutions come from the lab, and that a physician-researcher is the one truly capable of changing patients' lives," Al Mansouri sees her experience at the Mayo Clinic as a rare opportunity to acquire advanced research skills in a rigorous scientific environment - skills she hopes to use to help develop local research programmes led by Emirati talent."I aspire to be part of a fully integrated Emirati research ecosystem, one that contributes to innovative treatment solutions for chronic diseases and places the UAE at the forefront of global medical innovation," she completing her experience at Mayo Clinic, Al Mansouri hopes to transfer the knowledge gained back to the UAE by helping establish specialised research centres in diagnostic medicine and gene therapy, and by participating in the development of academic programmes that support a new generation of physician-researchers."In the UAE, we have the will, the resources, and supportive leadership. What we need now, as young people, is to take responsibility for turning these opportunities into scientific achievements that serve humanity," Al Mansouri also expressed her deep gratitude to the UAE's wise leadership for their commitment and care towards students, and their belief in the role of youth in national development by providing them with exceptional educational and research Mansouri extended special thanks to the Khalifa Bin Zayed Al Nahyan Foundation for Humanitarian Work for its continuous support and pioneering efforts in offering academic, practical, and research development opportunities at prestigious international institutions. She noted that this support is not just a show of trust - it's a true investment in the nation's future and a firm belief in the capabilities of Emirati youth to excel and contribute meaningfully to the development journey. Source: Aletihad - Abu Dhabi
Web Release
13-05-2025
- Web Release
Mayo Clinic researchers identify proteins linked to immunotherapy resistance in metastatic colorectal cancer
A discovery by Mayo Clinic researchers may help explain why immunotherapy hasn't been helpful for many patients with metastatic colorectal cancer. In findings published in Clinical Cancer Research, the team identified specific proteins — fibronectin and smooth muscle actin — within colorectal cancer tissues that are associated with resistance to immunotherapy treatment. Immunotherapy is a major advance in treating cancer, but many patients, including those with metastatic colorectal cancer, do not respond to it. Until now, researchers have not known why. 'We need predictive biomarkers to guide the selection of immunotherapy for patients,' says medical oncologist and gastroenterologist Frank Sinicrope, M.D. , the senior author of the study. 'Identifying those who may have resistance to treatment can be useful because then we can spare them from receiving treatment that may not be beneficial and could produce significant toxicities.' The research team used digital spatial profiling, an advanced technology that simultaneously analyzes the expression of multiple proteins and where they are located within tissues. This approach allowed researchers to zoom in to get a bird's eye view of a tumor that includes proteins both within and surrounding the tumor cells and how they interact. Dr. Sinicrope compares the spatial tools to an aerial view of a neighborhood where one can see relationships between driveways, houses, yards and neighboring structures. Similarly, this detailed view provides physicians and researchers with critical information about the proteins in and around a patient's cancer, potentially informing the best treatment for the patient. 'We wanted to learn more about the patients who did not respond to immunotherapy. We investigated the leading edge of the tumor where cancer cells are invading and where the immune system is attempting to fight the cancer,' says Dr. Sinicrope. 'It's like a battle going on here and we're getting a snapshot into who is in attendance.' The researchers focused on 10 regions at the invasive margin of a tumor. They applied digital spatial profiling to investigate 71 distinct proteins in both the tumor's epithelial compartment and the surrounding stromal compartment. Fibronectin and smooth muscle actin are two extracellular matrix proteins that were found in the epithelial region of the tumor and were associated with resistance to immunotherapy and shorter time before disease progression. Upon further analysis, the researchers observed that cancer-associated fibroblasts were producing these proteins. The evidence, they say, suggests that these proteins can contribute to suppression of the anti-tumor immune response. The discovery offers a step toward more personalized and effective colorectal cancer treatments. Review the study for a complete list of authors, disclosures and funding.
